跳至主要内容
临床试验/NCT01498367
NCT01498367已完成不适用

Renewing Health RCT for the Evaluation of Life-long Tele-monitoring of Patients With Diabetes Mellitus Type 2 in Central Greece

Regional Health Authority of Sterea & Thessaly1 个研究点 分布在 1 个国家目标入组 154 人开始时间: 2011年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
154
试验地点
1
主要终点
Health related quality of life of the patients measured by the SF-36 version 2 questionnaire

研究概览

简要总结

To evaluate whether patients with type 2 diabetes mellitus can be followed by simplified, centralized and large scale tele-monitoring of blood glucose levels and blood pressure, and whether this intervention produces health and economic benefits when introduced without major changes to the existing organization of a large tertiary care center.

详细描述

The present study aims to examine the clinical and financial effects and the patients' perception and satisfaction of home telemedicine support system for diabetes management versus standard (usual) care. In the intervention group the patients will be provided with a blood glucose meter and a mobile phone and their data will be transferred via the mobile to the regional database and will be assessed by the allocated care team. Appropriate counseling on treatment and symptoms or problems related to diabetes will also be provided.

Measurements of HbA1c will be taken to assess glycaemic control while the dietary and the exercise habits will be assessed by the use of questionnaires. In addition the patients' satisfaction from the use of the telemedicine service will be studied. A Cost-Effective Analysis and Cost Utility Analysis will be applied to evaluate the tele-health service compared with the usual care from the health and social perspective. The effect of the tele-health service in the organization structure of the outpatient hospital department will be evaluated with a qualitative study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Diagnosis of type 2 Diabetes
  • •HbA1c > 53 mmol/mol (7.0 % according to NGSP)
  • •Capability to use the devices provided
  • •Being cognitively able to participate
  • •Capability of filling in questionnaires in german or greek language
  • •Absence of severe comorbidity prevalent on diabetes with life expectancy < 12 months

排除标准

  • •Pregnancy

研究组 & 干预措施

Usual care

No Intervention

Participants in the control group receive usual care. Usual care consists of regular visits to the specialist when required. In the occasion of the visit, HbA1c and glucose measurements are performed and the current oral or insulin therapy is modified if necessary. Patients also receive basic education in the management of diabetes.

Telemonitoring of diabetes 2 patients

Experimental

Patients will have one educational visit to set up the system and explain how it works. Patients will download their measurements from their tele-glucose meter to their mobile phone and the data will be transferred to the regional database. The care team (a nurse specially trained and the allocated physician) will regularly access the patient's home diary, and will provide the appropriate counselling and medication changes as frequently as necessary. In addition to blood glucose measurements, routine questions about symptoms and eventual difficulties related to diabetes as well as diabetic management will be routinely captured and reported.

干预措施: Telemonitoring of patients with diabetes type 2 (Procedure)

结局指标

主要结局

Health related quality of life of the patients measured by the SF-36 version 2 questionnaire

时间窗: 12 months minimum- at the entry point of the intervention and the end.

HbA1c levels

时间窗: 12 months minimum - at the entry point and every 3 months.

Glycated hemoglobin (HbA1c) levels at the entry point and every 3 months (for a period of 12 months minimum)

次要结局

  • Nutrition habits assessed by validated questionnaire.(12 months minimum- at the entry point of the intervention and the end.)
  • Emotional functioning in diabetes assessed by the "Problem areas in diabetes questionnaire - PAID © 1999 Joslin Diabetes Center"(12 months minimum- at the entry point of the intervention and the end.)
  • Physical activity measured by the "International Physical Activity Questionnaire" (IPAQ)(12 months minimum- at the entry point of the intervention and the end.)
  • Patients' Acceptance-Satisfaction measured by the WSD Questionnaire(at 2nd and at 12th month)
  • Economic Evaluation (Cost-Effective Analysis- Cost Utility Analysis)(12 months minimum)

研究者

发起方
Regional Health Authority of Sterea & Thessaly
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Georgios Koukoulis

Associate Proffesor, Director of the Endocrinology and Metabolic Diseases Department, University Hospital of Larissa

Regional Health Authority of Sterea & Thessaly

研究点 (1)

Loading locations...

相似试验